| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26436-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-54553-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90523-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12072-0.025mg | |||
![Immunohistochemistry: Proprotein Convertase 9/PCSK9 Antibody (7F2) [NBP3-26436] - Image of Proprotein Convertase 9/PCSK9 Antibody (7F2) diluted at 1:100 and staining in paraffin-embedded human colon cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.](http://images.novusbio.com/fullsize/nbp3-26436_rabbit-proprotein-convertase-9-pcsk9-mab-7f2-2722024856321.jpg "Immunohistochemistry: Proprotein Convertase 9/PCSK9 Antibody (7F2) [NBP3-26436] - Image of Proprotein Convertase 9/PCSK9 Antibody (7F2) diluted at 1:100 and staining in paraffin-embedded human colon cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.")
![Western Blot: Proprotein Convertase 9/PCSK9 Antibody (7F2) [NBP3-26436] - Positive Western Blot detected in: PC-3 whole cell lysate. All lanes: Proprotein Convertase 9/PCSK9 Antibody at 1: 2000 Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 75, 21 kDa Observed band size: 60, 75 kDa](http://images.novusbio.com/fullsize/nbp3-26436_rabbit-proprotein-convertase-9-pcsk9-mab-7f2-282202411363020.jpg)
![Immunocytochemistry/Immunofluorescence: Insulysin/IDE Antibody (S04-4E8) [NBP3-19987] - Immunocytochemistry of Insulysin/IDE (green) in hela using NBP3-19987 at dilution 1/50, and DAPI (blue)](http://images.novusbio.com/fullsize/nbp3-19987_rabbit-insulysin-ide-mab-s04-4e8-113202515145425.jpg "Immunocytochemistry/Immunofluorescence: Insulysin/IDE Antibody (S04-4E8) [NBP3-19987] - Immunocytochemistry of Insulysin/IDE (green) in hela using NBP3-19987 at dilution 1/50, and DAPI (blue)")
![Western Blot: Insulysin/IDE Antibody [NB100-61667] - (1ug/ml) staining of Mouse Brain lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/Insulysin-IDE-Antibody-Western-Blot-NB100-61667-img0003.jpg "Western Blot: Insulysin/IDE Antibody [NB100-61667] - (1ug/ml) staining of Mouse Brain lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.")
![Western Blot: ARH Antibody (OTI7A5) - Azide and BSA Free [NBP2-71791] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ARC.](http://images.novusbio.com/fullsize/ARH-Antibody-OTI7A5-Azide-and-BSA-Free-Western-Blot-NBP2-71791-img0001.jpg "Western Blot: ARH Antibody (OTI7A5) - Azide and BSA Free [NBP2-71791] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ARC.")
![Western Blot: Insulysin/IDE Antibody [NBP2-16914] - Sample (30 ug of whole cell lysate) A: A549 7. 5% SDS PAGE gel, diluted at 1:1000.](http://images.novusbio.com/fullsize/Insulysin-IDE-Antibody-Western-Blot-NBP2-16914-img0002.jpg "Western Blot: Insulysin/IDE Antibody [NBP2-16914] - Sample (30 ug of whole cell lysate) A: A549 7. 5% SDS PAGE gel, diluted at 1:1000.")
![<b>Genetic Strategies Validation. </b>Wild-type (WT) and IDE knockout (KO) HeLa cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with IDE antibody [N1N3] (NBP2-16914) diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.](http://images.novusbio.com/fullsize/nbp2-16914_rabbit-polyclonal-insulysin-ide-antibody-western-blot-261120251842314.jpg)
![Immunohistochemistry-Paraffin: VLDLR Antibody (VLDLR/1337) [NBP2-53351] - Formalin-fixed, paraffin-embedded human Pancreas stained with VLDL-Receptor Monoclonal Antibody (VLDLR/1337).](http://images.novusbio.com/fullsize/VLDLR-Antibody-VLDLR-1337-Immunohistochemistry-Paraffin-NBP2-53351-img0001.jpg "Immunohistochemistry-Paraffin: VLDLR Antibody (VLDLR/1337) [NBP2-53351] - Formalin-fixed, paraffin-embedded human Pancreas stained with VLDL-Receptor Monoclonal Antibody (VLDLR/1337).")
![Western Blot: Proprotein Convertase 9/PCSK9 Antibody [NBP1-51923] - HEK293 lysate (10ug protein in RIPA buffer) overexpressing Human PCSK9 with C-terminal MYC tag probed with NBP1-51923 (0.5ug/ml) in Lane A and probed with anti-MYC Tag (1/1000) in lane C. Mock-transfected HEK293 probed with NBP1-51923 (1mg/ml) in Lane B. Primary incubations were for 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/Proprotein-Convertase-9-PCSK9-Antibody-Western-Blot-NBP1-51923-img0006.jpg "Western Blot: Proprotein Convertase 9/PCSK9 Antibody [NBP1-51923] - HEK293 lysate (10ug protein in RIPA buffer) overexpressing Human PCSK9 with C-terminal MYC tag probed with NBP1-51923 (0.5ug/ml) in Lane A and probed with anti-MYC Tag (1/1000) in lane C. Mock-transfected HEK293 probed with NBP1-51923 (1mg/ml) in Lane B. Primary incubations were for 1 hour. Detected by chemiluminescence.")
![Western Blot: Insulysin/IDE Antibody (8O8F3) [NBP3-15352] - Western blot analysis of extracts of various cell lines, using Insulin-degrading enzyme (Insulysin/IDE) Rabbit mAb (NBP3-15352) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.](http://images.novusbio.com/fullsize/Insulysin-IDE-Antibody-8O8F3-Western-Blot-NBP3-15352-img0001.jpg "Western Blot: Insulysin/IDE Antibody (8O8F3) [NBP3-15352] - Western blot analysis of extracts of various cell lines, using Insulin-degrading enzyme (Insulysin/IDE) Rabbit mAb (NBP3-15352) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 1s.")
![Flow Cytometry: LDLR Antibody (032) [NBP2-90523] - Flow cytometric analysis of Mouse LDLR expression on Raw264.7. Cells were stained with purified anti-Mouse LDLR, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/LDLR-Antibody-032-Flow-Cytometry-NBP2-90523-img0001.jpg "Flow Cytometry: LDLR Antibody (032) [NBP2-90523] - Flow cytometric analysis of Mouse LDLR expression on Raw264.7. Cells were stained with purified anti-Mouse LDLR, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.")
![Immunocytochemistry/Immunofluorescence: LDLR Antibody (032) [NBP2-90523] - Immunofluorescence staining of Mouse LDLR in raw264.7 cells. Cells were fixed with 4% PFA, blocked with 10% serum, and incubated with NBP2-90523 antibody (1:100) at 4C overnight. Then cells were stained with the Alexa Fluor(R) 488-conjugated (left panel, captured by laser confocal scanning microscope; right panel, captured by fluorescence microscope) Goat Anti-rabbit IgG Secondary antibody(green), counterstained with DAPI (blue). Positive staining was localized to plasma membrane.](http://images.novusbio.com/fullsize/nbp2-90523_rabbit-monoclonal-ldlr-antibody-032-235202511254411.png)